Mitochondrial DNA haplogroup N is associated good outcome of gastric cancer

Tumor Biology

Volumn 35, Issue 12, 2014, Pages 12555-12559

  Wang, Cuiju ^a   Wang, Yingnan ^a   Wang, Huiying ^a   Zhang, Ruixing ^a   Guo, Zhanjun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

D loop; Gastric cancer; mtDNA; Outcome; SNPs

Indexed keywords

ANTINEOPLASTIC AGENT; MITOCHONDRIAL DNA;

ADULT; ALLELE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE FREQUENCY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL HAPLOGROUP; MITOCHONDRIAL HAPLOGROUP M; MITOCHONDRIAL HAPLOGROUP N; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; AGED; CANCER GRADING; CANCER STAGING; GENETIC ASSOCIATION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; DNA, MITOCHONDRIAL; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; PATIENT OUTCOME ASSESSMENT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84925283482     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2575-8     Document Type: Article

References (33)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
2. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol. 2006;20:633–49.
3. Correa P. Gastric cancer: overview. Gastroenterol Clin N Am. 2013;42:211–7.
4. Theuer CP. Asian gastric cancer patients at a southern California comprehensive cancer center are diagnosed with less advanced disease and have superior stage-stratified survival. Am Surg. 2000;66:821–6.
5. Schwarz RE, Zagala-Nevarez K. Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity. Eur J Surg Oncol (EJSO). 2002;28:214–9.
6. Kim T, Kim HH, Joo H. Mitochondrial DNA mutation and oxidative stress. Interdiscip Bio Central. 2011;3:1–8.
7. Penta JS, Johnson FM, Wachsman JT, Copeland WC. Mitochondrial DNA in human malignancy. Mutat Res Rev Mutat Res. 2001;488:119–33.
8. Croteau DL, Bohr VA. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem. 1997;272:25409–12.
9. Lin CS, Wang LS. Mitochondrial DNA instability in human cancers. Formos J Surg. 2013;46:71–5.
10. Lièvre A, Chapusot C, Bouvier AM, Zinzindohoué F, Piard F, Roignot P, et al. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol. 2005;23:3517–25.
11. Tan DJ, Chang J, Liu LL, Bai RK, Wang YF, Yeh KT, et al. Significance of somatic mutations and content alteration of mitochondrial DNA in esophageal cancer. BMC Cancer. 2006;6:93.
12. Aikhionbare FO, Mehrabi S, Kumaresan K, Zavareh M, Olatinwo M, Odunsi K, et al. Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages. J Carcinog. 2007;6:1.
13. Gao Y, Zhao G, Diao L, Guo Z, et al. Identification of sequence polymorphisms in the D-Loop region of mitochondrial DNA as a risk factor for non-Hodgkin lymphoma. Mitochondrial DNA. 2013;1–3.
14. Zhang J, Guo Z, Bai Y, Cui L, Zhang S, Xu J. Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for renal cell carcinoma. Biomed Rep. 2013;1:563–6.
15. Wang C, Zhang F, Fan H, Peng L, Zhang R, Liu S, et al. Sequence polymorphisms of mitochondrial D-Loop and hepatocellular carcinoma outcome. Biochem Biophys Res Commun. 2011;406:493–6.
16. Ding C, Li R, Wang P, Fan H, Guo Z. Sequence polymorphisms of the mitochondrial displacement loop and outcome of non-small cell lung cancer. Exp Ther Med. 2012;3:861–4.
17. Wang H, Wang Y, Zhao Q, Guo Z, Zhang F, Zhao Y, et al. Identification of sequence polymorphisms in the D-Loop region of mitochondrial DNA as a risk factor for gastric cancer. Mitochondrial DNA. 2014.
18. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077–9.
19. Hofmann M, Stoss O, Shi D, Büttner R, van de Vijver M, Kim W, et al. Assessment of a HER2 scoring system for gastric cancer: results from a validation study. Histology. 2008;52:797–805.
20. Wang M, Bai J, Tan Y, Wang S, Tian Y, Gong W, et al. Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population. Int J Cancer. 2011;129:1207–13.
21. Chu HY, Gu DY, Xu M, Xu Z, Gong Y, Gong W, et al. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. Mutagenesis. 2013;28:441–6.
22. Zhang R, Zhang F, Wang C, Wang S, Shiao YH, Guo Z. Identification of sequence polymorphism in the D-loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology. J Exp Clin Cancer Res. 2010;29:130.
23. Guo Z, Yang H, Wang C, Liu S. Mitochondrial DNA haplogroup M is associated with late onset of hepatocellular carcinoma. Exp Ther Med. 2012;3:499–502.
24. Cheng M, Guo Z, Li H, Li C, Geng C. Identification of sequence polymorphisms in the mitochondrial displacement loop as risk factors for sporadic and familial breast cancer. Tumour Biol. 2014;1–5.
25. González AM, Larruga JM, Abu-Amero KK, Shi Y, Pestano J, Cabrera VM. Mitochondrial lineage M1 traces an early human backflow to Africa. BMC Genomics. 2007;8:223.
26. Stoneking M. Hypervariable sites in the mtDNA control region are mutational hotspots. Am J Hum Genet. 2000;67:1029–32.
27. Ding C, Li R, Wang P, Jin P, Li S, Guo Z. Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for lung cancer. Mitochondrial DNA. 2012;23:251–4.
28. Zhang R, Wang R, Zhang F, Wu C, Fan H, Li Y, et al. Single nucleotide polymorphisms in the mitochondrial displacement loop and outcome of esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2010;29:155.
29. Diao L, Wei G, Su H, Li H, Song J, Gao Y, et al. Sequence polymorphisms in the D-loop region of mitochondrial DNA and outcome of non-Hodgkin lymphoma. Mitochondrial DNA. 2013;1–4.
30. Moraes CT, Srivastava S, Kirkinezos I, Oca-Cossio J, Van Waveren C, Woischnick M, et al. Mitochondrial DNA structure and function. Mitochondrial function and dysfunction. Int Rev Neurobiol. 2002;53:3–23.
31. Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene. 2006;25:4647–62.
32. Wallace DC. Mitochondria and cancer: Warburg addressed. Cold Spring Harb Symp Quant Biol. 2005;70:363–74.
33. Lee HC, Chang CM, Chi CW. Somatic mutations of mitochondrial DNA in aging and cancer progression. Ageing Res Rev. 2010;9:S47–58.